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ABSTRACT
Objective: The purpose of this study was to examine the role of the genital mycoplasmas Mycoplasma
hominis and Ureaplasma urealyticum as causes of bacteremia in a tertiary referral obstetrical, gy-
necological, and neonatal intensive care facility, over a period of 12 years from 1983 to 1994
inclusively.
Methods: All clinically significant blood cultures were reviewed and the percentage of septicemic
episodes for genital mycoplasmas was compared to the total isolation rate, including conventional
bacteria.
Results: The overall positivity rate for all pathogenic organisms isolated from the blood cultures
of infants ranged from 4.5% to 7.7% per annum. U. urealyticum represented 0.8% of these positive
isolates and M. hominis 0.4%. For adults, the overall positivity rate from blood cultures ranged from
6.5% to 13.5%, with U. urealyticum representing 9.6% of these positive isolates and M. hominis 9.9%.
Conclusions: With M. hominis having an established role in such clinical entities as postabortal and
postpartum fever and U. urealyticum strongly implicated with chronic lung disease in low birth
weight infants, it is appropriate to examine blood cultures for genital mycoplasmas in an obstetric
institution. Infect. Dis. Obstet. Gynecol. 4:329-332, 1996. (C) 1997 Wiley-Liss, Inc.
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found as part of the endogenous microflora of the
vagina of sexually active women, with colonization
rates of 20% and 40-70%, respectively. 1,z However,
a clearer understanding of their role in disease has
been made in the past decade. For example, it is
now well recognized that M. hominis has an estab-
lished role in pelvic inflammatory disease (PID), as
researchers have not only isolated M. hominis in
pure culture from Fallopian tubes of women diag-
nosed laparoscopically with PID, but have also
documented a specific immune response to the or-
ganism, e,3 Moreover, it has an established role in
postabortal and postpartum fever,e,4-6 pyelonephri-
tis,e’6-8 pneumonia, and meningitis in newborns,e,9
while U. urealyticum not only has a role in preterm
delivery, via chorioamnionitis, but also causes neo-
natal pneumonia and meningitis and is strongly as-
sociated with chronic lung disease in low birth
weight infants,z,1,11
It is important to recognize that these potential
pathogens have a limited spectrum of susceptibility
to conventional antimicrobial agents. For example,
they are both susceptible to tetracyclines, but not
to the [3-1actams, yet have differential susceptibil-
ity patterns to the macrolides and lincosamides. U.
urealyticum is susceptible to erythromycin but not
clindamycin, and the reverse is true for M. homi-
his.TM Furthermore, these bacteria do not grow
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TABLE I. Significant blood culture isolates from an obstetrical, gynecological, and neonatal population from
1983 to 1994 inclusively
1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 Average
Total population
No. of isolates 60 41 47 40 35 49 58 91 109 91 84 121 69
Positivity ratemU, urealyticum (%) 5.0 2.4 4.3 2.5 5.7 16.3 3.4 2.2 4.6 2.2 2.4 3.3 4.5
Positivity rate--M, hominis (%) 10.0 4.9 6.4 5.0 5.7 8.2 5.2 0.0 3.7 3.3 0.0 3.3 4.6
Adults
Total No. of isolates 18 15 20 18 14 21 29 34 58 36 22 29 26
S. aureus 3 0 0 7 3 4 4 3 2
Streptococci 0 0 4 4 2 4 15 7 2 7
Enteric gram-negative rods 5 9 7 6 2 6 8 12 13 II 9 9
Anaerobic bacteria 3 3 3 0 4 7 4 10 4 0
U. urealyticum 2 2 7 2 5 2 2 4
M. hominis 6 3 2 2 3 3 0 4 3 0 4
Other organisms 0 2 2 3 0 9 7 5 6 2
Positivity rate--U, urealyticum (%) I. 6.7 5.0 5.6 14.3 33.3 3.4 5.9 8.6 5.6 9. 13.8 9.6
Positivity ratemM, hominis (%) 33.3 6.7 15.0 I1.1 14.3 14.3 10.3 0.0 6.9 8.3 0.0 13.8 9.9
Babies
Total No. of isolates 42 26 27 22 21 28 29 57 51 55 62 92 43
S. aureus 0 2 0 2 0 9 3 2 3 3 4 3
Coagulase-negative staphylococci 2 4 9 6 4 3 9 16 21 30 40 60
Streptococci 10 5 4 4 6 6 17 12 10 13 13
Enteric gram-negative rods 21 9 6 5 10 3 9 9 6 6 9
Anaerobic bacteria 3 4 0 4 2 2 6 5 0 0 3
U. urealyticum 0 0 0 0 0 0 0 0
M. hominis 0 0 0 0 0 0 0 0 0 0
Other organisms 5 0 3 0 7 4 6 4 4
Positivity rateU, urealyticum (%) 2.4 0.0 3.7 0.0 0.0 3.6 3.4 0.0 0.0 0.0 0.0 0.0 0.8
Positivity rateM, hominis (%) 0.0 3.8 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4
readily in standard media and require special cul-
ture media and laboratory conditions for their de-
tection and identification in clinical samples such
as blood, cerebrospinal fluid, and genital swabs,s,ll
In particular, blood culture media containing so-
dium polyanetholesulfonate (SPS) inhibit the
growth of both of these bacteria,s
We reviewed 3/1. hominis and U. urealyticurn as
causes of bacteremia in an obstetrical, gynecologi-
cal, and neonatal setting and contrasted them with
conventional pathogens isolated over a 12-year pe-
riod.
MATERIALS AND METHODS
The Royal Women’s Hospital, Melbourne, is a ter-
tiary care obstetrical, gynecological, and perinatal
university hospital and the largest in the State of
Victoria, Australia. There are approximately 8,000
deliveries per annum. The neonatal intensive care
unit has 12 ventilator beds, while the special care
nursery has 42 beds.
For the period 1983-1994 inclusively, we re-
viewed the percentage of blood cultures positive
for the genital mycoplasmas 3//. horninis and U. urea-
lyticum and compared these with conventional or-
ganisms recognized as causes of septicemia. For
adults these included enteric gram-negative rods,
Staphylococcus aureus, Streptococcus sp. (groups A, B,
C, D, and G, S. milleri, S. pneumoniae, S. salivaris, S.
oralis, and the viridans group), and Enterococcus sp.
and additionally for neonates, coagulase-negative
staphylococci, where the same species was in more
than one bottle and in the clinical setting of sepsis.
Those isolates which were considered contami-
nants (e.g., P. acnes and coagulase-negative staph-
ylococci) were excluded. This was not a popula-
tion-based study for bacteremia; it was an assess-
ment of positive blood cultures obtained from
patients who were being screened on clinical
grounds for septicemia. Indications for requesting
blood cultures included for adults, clinical signs
consistent with septicemia (persistent fever
>38C, with rigors _+ hypotension) and laboratory
indications of sepsis (e.g., leukocytosis with left
shift). For neonates the indications included tem-
perature instability, fever, persistent apneic epi-
sodes, bradycardia, acidosis, peripheral shutdown,
or fitting.
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TABLE 2. Clinical settings of significant blood culture isolates
Streptococcus Enteric Anaerobic
Clinical setting S. aureus CoNS sp. GNB bacteria
Other
U. urealyticum M. hominis organisms
Adults
Antepartum pyelonephritis
Sepsis postcesarean section
Sepsis postpartum
Sepsis abortion
Sepsis placenta privea
Chorioamnionitis
Sepsis gynecological oncology
Sepsis central venous line
Sepsis postvaginal
hysterectomy
Postdilation and curettage
Post termination of
pregnancy
Pelvic abscess
Ectopic pregnancy--
salpingectomy
Pelvic infection
Pneumonia
Meningitis
Babies
Sepis, skin pustules
Comphalitis
Urinary tract infection
Necrotizing enterocolitis
Meningitis
Early-onset sepsis
Late-onset sepsis
aCoNS, coagulase-negative Staphylococcus sp.; GNB, gram-negative bacteremia.
blncludes Candida albicans, L. monocytogenes, Pseudomonas sp., Hemophilus sp., Gardnerella vaginalis, C. jejuni, N. mucosa.
From 1983 to 1986, the routine blood culture
media used were an anaerobic Schaedler broth and
an aerobic biphasic tryptone soya agar with 50 ml of
tryptone soya broth medium, free of SPS, as pre-
viously described.4 Media were incubated at 37C
for 7 days and inspected daily. Subculture of ob-
served growth, as well as blind subculture at 48 h
were performed as previously described, including
culture for conventional aerobic and anaerobic bac-
teria and also for genital mycoplasmas using ure-
aplasma differential agar (modified A7) from the
SPS-free aerobic medium.4 Subsequently, in 1987,
a change was made to the Bactec blood culture
system (Becton, Dickinson & Co., Cockeysville,
MD). The media used for adults were 6B (aerobic
enriched tryptic soya broth) and 7DX (anaerobic
enriched tryptic soya broth without SPS). For in-
fants the media used were PedsPlus (enriched
tryptic soya broth with antimicrobial removing res-
ins) and 7DX. All Bactec media were incubated for
7 days at 37C. The growth index was measured
using the Bactec reader 460. Blind subculture was
made from the SPS-free 7DX medium routinely
after 48 h onto a modified A7 agar and incubated
anaerobically for 2 days. Identification ofM. hominis
and U. urealyticum was as previously described.4,s
RESULTS
U. urea/yticum and M. hominis as a percentage of
total significant blood culture isolates for the total
population, with a breakdown into adults and in-
fants, are shown in Table 1. The number of blood
culture sets per year for the 12-year study period
ranged from 622 to 1,196 for infants and 365 to 542
for adults. Overall the positivity rates for all patho-
genic organisms for infants ranged from 4.5% to
7.7% and for adults 6.5% to 13.5%. U. urealyticum
represented 0.8% of these positive isolates for in-
fants and 9.6% for adults. Similarly, M. hominis rep-
resented 0.4% of these positive isolates for infants
and 9.9% for adults.
The clinical context for adult cases included
postabortal sepsis, postpartum endometritis, cho-
rioamnionitis, fever plus retained products of con-
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ception, postpartum fever and pelvic collection, fe-
ver postremoval of intrauterine device, pelvic in-
fection, and fever postdilatation and curettage. For
infants, the clinical context included sepsis, men-
ingitis, and investigation following premature de-
livery.
Conventional pathogens were isolated in a di-
verse array of clinical settings and are detailed in
Table 2. In 9 instances, 31. hominis or U. urealyticum
was isolated in mixed culture. On 4 occasions they
were found together in the clinical setting of post-
partum sepsis, ell. hominis was also detected in com-
bination with Gardnerella vaginalis (chorioamnion-
itis), S. aureus (infected cesarean section wound),
and polymicrobial anaerobic bacteria (postpartum
sepsis). U. urealyticum was detected with Klebsiella
pneumoniae (infected uterine cancer) and G. vagina-
lis (cuff cellulitis, postvaginal hysterectomy) sepa-
rately.
CONCLUSIONS
For adults it can be seen that genital mycoplasmas
can contribute significantly to sepsis in an obstetric
and gynecological setting. While these organisms
are not highly pathogenic (they are not associated
with septic shock as is the case with gram-negative
bacillary sepsis), they contribute to increased bed
stay and costs associated with the investigation of
fever postpartum or postgynecological procedure.
Moreover, they are important to specifically recog-
nize as pathogens to ensure that appropriate anti-
microbial treatment is utilized, especially where
upper genital tract infection has occurred. Conven-
tional antibiotic regimens for PID with 13-1actams
are ineffective against these microorganisms. Al-
though in this review M. hominis and U. urealyticum
did not represent as high a proportion of positive
culture in infants compared to adult women, in the
compromised host setting of the preterm infant,
these organisms are important to recognize from
normally sterile sites. U. urealyticum has been
shown to cause meningitis 1,11 as well as being
strongly implicated in chronic lung disease of low
birth weight infants. 11,3,14 In conclusion, we be-
lieve that in a tertiary care obstetric, gynecological,
and neonatal intensive care facility it is worthwhile
and appropriate that the servicing microbiology
laboratory specifically examine blood culture for
the genital mycoplasmas in clinical settings where
mycoplasmaemia is suspected.
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